Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-23-000907
Filing Date
2023-02-09
Accepted
2023-02-09 16:02:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRIMECAP MANAGEMENT CO/CA/ calaa5_20923.htm SC 13G/A 26377
  Complete submission text file 0001085146-23-000907.txt   27843
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SC 13G/A

Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Subject) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88349 | Film No.: 23606123
SIC: 2834 Pharmaceutical Preparations